Doctor Dina Labib
Libin Cardiovascular Institute Of Alberta, Calgary (Canada)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients
Event: ESC Congress 2024
Topic: Hypertrophic Cardiomyopathy
Session: Hypertrophic cardiomyopathy: risk prediction and outcomes
Prevalence and predictors of right ventricular dysfunction in cancer patients treated with cardiotoxic chemotherapy - A prospective cardiovascular magnetic resonance study
Event: ESC Congress 2021 - The Digital Experience
Topic: Cardio-Oncology
Session: Cardiovascular Disease in Special Populations ePosters
Value of baseline clinical and CMR characteristics for the prediction of cancer therapeutics-related cardiac dysfunction: results from the Cardiotoxicity Prevention Research Initiative (CAPRI)
Event: ESC Congress 2020
Topic: Cardio-Oncology
Session: Cardiovascular Disease in Special Populations ePosters
